drugset / Trial / NCT03110874

Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control

NCT03110874

Phase 4 Completed 184 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupSingle-blindTreatment

Summary

A multi-center, randomized, open, non-inferiority, Phase 4 study

Timeline

Start
2015-10-08
Primary completion
2016-09-01
Completion
2017-05-10

Drugs

EvaluationDrugModalityDoseRoute
Background Fluticasone propionate Other / unclassified 250 ug Inhaled
Background Salmeterol Other / unclassified 72.5 ug Inhaled

Indications